Getting to the "Heart" of Cardiac Disease by Decreasing Mitochondrial Iron

被引：29

作者：

Chang, Hsiang-Chun ^{[1
]}

Shapiro, Jason S. ^{[1
]}

Ardehali, Hossein ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Cardiovasc Res Inst, 303 E Chicago Ave,Tarry 14-733, Chicago, IL 60611 USA

来源：

CIRCULATION RESEARCH | 2016年 / 119卷 / 11期

关键词：

anemia; heart failure; iron; mitochondria; myocardial reperfusion; FERRIC CARBOXYMALTOSE; DEFICIENCY; FAILURE; CHELATION;

D O I：

10.1161/CIRCRESAHA.116.309746

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Iron chelation rather than supplementation would be beneficial to patients with heart diseases. More effort should be devoted to the development of iron chelators that could target mitochondrial iron.

引用

页码：1164 / 1166

页数：3

共 13 条

[1] Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
Anker, Stefan D.
Comin Colet, Josep
Filippatos, Gerasimos
Willenheimer, Ronnie
Dickstein, Kenneth
Drexler, Helmut
Luescher, Thomas F.
Bart, Boris
Banasiak, Waldemar
Niegowska, Joanna
Kirwan, Bridget-Anne
Mori, Claudio
Rothe, Barbara von Eisenhart
Pocock, Stuart J.
Poole-Wilson, Philip A.
Ponikowski, Piotr
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) : 2436 - 2448
[2] Epidemiological associations between on and cardiovascular disease and diabetes
Basuli, Debargha
Stevens, Richard G.
Torti, Frank M.
Torti, Suzy V.
[J]. FRONTIERS IN PHARMACOLOGY, 2014, 5
[3] When less is more: novel mechanisms of iron conservation
Bayeva, Marina
Chang, Hsiang-Chun
Wu, Rongxue
Ardehali, Hossein
[J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2013, 24 (11) : 569 - 577
[4] Reduction in mitochondrial iron alleviates cardiac damage during injury
Chang, Hsiang-Chun
Wu, Rongxue
Shang, Meng
Sato, Tatsuya
Chen, Chunlei
Shapiro, Jason S.
Liu, Ting
Thakur, Anita
Sawicki, Konrad T.
Prasad, Sathyamangla V. N.
Ardehali, Hossein
[J]. EMBO MOLECULAR MEDICINE, 2016, 8 (03) : 247 - 267
[5] Hepcidin and iron regulation, 10 years later
Ganz, Tomas
[J]. BLOOD, 2011, 117 (17) : 4425 - 4433
[6] The role of iron in neurodevelopment: fetal iron deficiency and the developing hippocampus
Georgieff, Michael K.
[J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 : 1267 - 1271
[7] Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function
Lakhal-Littleton, Samira
Wolna, Magda
Carr, Carolyn A.
Miller, Jack J. J.
Christian, Helen C.
Ball, Vicky
Santos, Ana
Diaz, Rebeca
Biggs, Daniel
Stillion, Richard
Holdship, Philip
Larner, Fiona
Tyler, Damian J.
Clarke, Kieran
Davies, Benjamin
Robbins, Peter A.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (10) : 3164 - 3169
[8] Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction The TACT Randomized Trial
Lamas, Gervasio A.
Goertz, Christine
Boineau, Robin
Mark, Daniel B.
Rozema, Theodore
Nahin, Richard L.
Lindblad, Lauren
Lewis, Eldrin F.
Drisko, Jeanne
Lee, Kerry L.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (12): : 1241 - 1250
[9] On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
Pennell, D. J.
Carpenter, J. P.
Roughton, M.
Cabantchik, Z. I.
[J]. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2011, 13
[10] Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
Ponikowski, Piotr
van Veldhuisen, Dirk J.
Comin-Colet, Josep
Ertl, Georg
Komajda, Michel
Mareev, Viacheslav
McDonagh, Theresa
Parkhomenko, Alexander
Tavazzi, Luigi
Levesque, Victoria
Mori, Claudio
Roubert, Bernard
Filippatos, Gerasimos
Ruschitzka, Frank
Anker, Stefan D.
[J]. EUROPEAN HEART JOURNAL, 2015, 36 (11) : 657 - 668

← 1 2 →